Jon D. Piganelli

6.2k citations

90 papers · 4.9k indexed · 1 hit paper · h-index 42

Immunology top 1%
Surgery top 2%
Genetics top 1%
Molecular Biology top 5%
Endocrinology, Diabetes and Metabolism top 1%

Co-authors: Hubert M. Tse Massimo Trucco Meghan Delmastro-Greenwood Gina M. Coudriet Meghan L. Marré Jay K. Kolls Rita Bottino Kathryn Haskins
Topics: Diabetes and associated disorders (46 papers)Pancreatic function and diabetes (32 papers)Immune Cell Function and Interaction (26 papers)
Cited by: Immunology Genetics Endocrinology, Diabetes and Metabolism
Journals: Journal of Biological Chemistry Journal of Clinical Investigation Nature Communications
Partner nations: United States Canada Japan

In The Last Decade

Jon D. Piganelli

90 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TH17 Cells Mediate Steroid-Resistant Airway Inflammation and Airway Hyperresponsiveness in Mice

2008 625 citations Laura McKinley, John F. Alcorn et al. The Journal of Immunology profile →

Peers

Countries citing papers authored by Jon D. Piganelli

Since Specialization

Citations

This map shows the geographic impact of Jon D. Piganelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon D. Piganelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon D. Piganelli more than expected).

Fields of papers citing papers by Jon D. Piganelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon D. Piganelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon D. Piganelli. The network helps show where Jon D. Piganelli may publish in the future.

Co-authorship network of co-authors of Jon D. Piganelli

This figure shows the co-authorship network connecting the top 25 collaborators of Jon D. Piganelli. A scholar is included among the top collaborators of Jon D. Piganelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon D. Piganelli. Jon D. Piganelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Chicken or the Egg Dilemma: Understanding the Interplay between the Immune System and the β Cell in Type 1 Diabetes 2024 ·Cold Spring Harbor Perspectives in Medicine ·M. Hansen,Pravil Pokharel,Jon D. Piganelli,Lori Sussel	2
2	Epithelial NAD+ depletion drives mitochondrial dysfunction and contributes to intestinal inflammation 2023 ·Frontiers in Immunology ·Elizabeth Novak,(unknown),(unknown),Brian D. Griffith,(unknown),(unknown),Corinne Schneider,Brian Firek,Matthew B. Rogers,Michael J. Morowitz,Jon D. Piganelli,Qian Wang,Kevin P. Mollen	10
3	Glycolysis Inhibition Induces Functional and Metabolic Exhaustion of CD4+ T Cells in Type 1 Diabetes 2021 ·Frontiers in Immunology ·Christina Martins,Lee Ann New,(unknown),(unknown),Kasey R. Cargill,(unknown),(unknown),Jon D. Piganelli	51
4	A Noncanonical Role for Plasminogen Activator Inhibitor Type 1 in Obesity-Induced Diabetes 2019 ·American Journal Of Pathology ·Gina M. Coudriet,John Stoops,Anne Orr,Bharat Bhushan,Kelly Koral,Sojin Lee,(unknown),H. Henry Dong,George K. Michalopoulos,Wendy M. Mars,Jon D. Piganelli	10
5	Inflammation-Induced Citrullinated Glucose-Regulated Protein 78 Elicits Immune Responses in Human Type 1 Diabetes 2018 ·Diabetes ·Mijke Buitinga,(unknown),(unknown),Inne Crèvecoeur,(unknown),Meiling Yang,Marco Bugliani,(unknown),Meghan L. Marré,Dana P. Cook,Etienne Waelkens,Roberto Mallone,Jon D. Piganelli,Piero Marchetti,Mark J. Mamula,Rita Derua,Eddie A. James,Chantal Mathieu,Lut Overbergh	60
6	Reactive Oxygen Species and Their Implications on CD4 ⁺ T Cells in Type 1 Diabetes 2017 ·Antioxidants and Redox Signaling ·(unknown),Jon D. Piganelli	18
7	Reactive oxygen species are required for driving efficient and sustained aerobic glycolysis during CD4+ T cell activation 2017 ·PLoS ONE ·(unknown),(unknown),Elizabeth Novak,Christina Martins,Kevin P. Mollen,Jon D. Piganelli	76
8	β cell ER stress and the implications for immunogenicity in type 1 diabetes 2015 ·Frontiers in Cell and Developmental Biology ·Meghan L. Marré,Eddie A. James,Jon D. Piganelli	83
9	Cytokine and Chemokine Production by Human Pancreatic Islets Upon Enterovirus Infection 2012 ·Diabetes ·Barbara M. Schulte,Kjerstin Lanke,Jon D. Piganelli,Esther D. Kers‐Rebel,Rita Bottino,Massimo Trucco,Richard Huijbens,Timothy R. D. J. Radstake,Marten A. Engelse,Eelco J.P. de Koning,Jochem M. D. Galama,Gosse J. Adema,Frank J. M. van Kuppeveld	49
10	Modulation of Redox Balance Leaves Murine Diabetogenic TH1 T Cells “LAG-3-ing” Behind 2012 ·Diabetes ·Meghan Delmastro-Greenwood,Alexis Styche,Massimo Trucco,Creg J. Workman,Dario A.A. Vignali,Jon D. Piganelli	34
11	Neuroprotective Efficacy from a Lipophilic Redox-Modulating Mn(III) N-Hexylpyridylporphyrin, MnTnHex-2-PyP: Rodent Models of Ischemic Stroke and Subarachnoid Hemorrhage 2011 ·Journal of Pharmacology and Experimental Therapeutics ·Huaxin Sheng,Ivan Spasojević,Hubert M. Tse,Jin Yong Jung,(unknown),Zhiquan Zhang,Jon D. Piganelli,Ines Batinić‐Haberle,David S. Warner	59
12	Superoxide Production by Macrophages and T Cells Is Critical for the Induction of Autoreactivity and Type 1 Diabetes 2011 ·Diabetes ·Terri C. Thayer,Matthew J. Delano,Chao Liu,Jing Chen,Lindsey E. Padgett,Hubert M. Tse,(unknown),Jon D. Piganelli,Lyle L. Moldawer,Clayton E. Mathews	80
13	A multivalent vaccine for type 1 diabetes skews T cell subsets to Th2 phenotype in NOD mice 2011 ·Immunologic Research ·Ming Lin,Hubert M. Tse,Meghan Delmastro-Greenwood,Suzanne Bertera,(unknown),Robert Lakomy,Jing He,(unknown),Gina M. Coudriet,Massimo Pietropaolo,Massimo Trucco,Jon D. Piganelli	18
14	Chromogranin A is an autoantigen in type 1 diabetes 2010 ·Nature Immunology ·Brian D. Stadinski,Thomas Delong,Nichole Reisdorph,Richard Reisdorph,Roger Powell,Michael Armstrong,Jon D. Piganelli,Gene Barbour,Brenda Bradley,Frances Crawford,Philippa Marrack,Sushil K. Mahata,John W. Kappler,Kathryn Haskins	286
15	TRIF and IRF-3 Binding to the TNF Promoter Results in Macrophage TNF Dysregulation and Steatosis Induced by Chronic Ethanol 2008 ·The Journal of Immunology ·Xuejun Zhao,Qing Dong,(unknown),Jon D. Piganelli,(unknown),Jakob Reiser,Jay K. Kolls	100
16	TH17 Cells Mediate Steroid-Resistant Airway Inflammation and Airway Hyperresponsiveness in Micebreakdown → 2008 ·The Journal of Immunology ·Laura McKinley,John F. Alcorn,Alanna Peterson,Rachel DuPont,(unknown),Alison Logar,Adam C. Henry,Charles G. Irvin,Jon D. Piganelli,Anuradha Ray,Jay K. Kolls	625
17	Antioxidant Levels Represent a Major Determinant in the Regenerative Capacity of Muscle Stem Cells 2008 ·Molecular Biology of the Cell ·Kenneth L. Urish,Joseph B. Vella,Masaho Okada,Bridget M. Deasy,Kimimasa Tobita,Bradley B. Keller,Baohong Cao,Jon D. Piganelli,Johnny Huard	72
18	Disruption of Innate-Mediated Proinflammatory Cytokine and Reactive Oxygen Species Third Signal Leads to Antigen-Specific Hyporesponsiveness 2007 ·The Journal of Immunology ·Hubert M. Tse,(unknown),(unknown),(unknown),Massimo Trucco,Jon D. Piganelli	82
19	Dendritic Cells Expressing Transgenic Galectin-1 Delay Onset of Autoimmune Diabetes in Mice 2006 ·The Journal of Immunology ·Marcelo J. Perone,Suzanne Bertera,(unknown),William J. Shufesky,Jon D. Piganelli,Linda G. Baum,Massimo Trucco,Adrián E. Morelli	61
20	Preeclampsia Activates Circulating Immune Cells with Engagement of the NF‐κB Pathway 2006 ·American Journal of Reproductive Immunology ·Patrizia Luppi,Hubert M. Tse,Kristine Y. Lain,Nina Markovic,Jon D. Piganelli,Julie A. DeLoia	69

About Jon D. Piganelli

Jon D. Piganelli is a scholar working on Immunology, Genetics and Clinical Biochemistry, having authored 90 papers that have together received 4.9k indexed citations. Recurring topics across this work include Diabetes and associated disorders (46 papers), Pancreatic function and diabetes (32 papers) and Immune Cell Function and Interaction (26 papers). The work is most often cited by research in Immunology (1.8k citations), Genetics (1.5k citations) and Endocrinology, Diabetes and Metabolism (781 citations). Jon D. Piganelli has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Hubert M. Tse, Massimo Trucco, Meghan Delmastro-Greenwood, Gina M. Coudriet, Meghan L. Marré, Jay K. Kolls, Rita Bottino, Kathryn Haskins, Eddie A. James and John F. Alcorn. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact